222 related articles for article (PubMed ID: 27164166)
21. Transcriptional networks in the liver: hepatocyte nuclear factor 6 function is largely independent of Foxa2.
Rubins NE; Friedman JR; Le PP; Zhang L; Brestelli J; Kaestner KH
Mol Cell Biol; 2005 Aug; 25(16):7069-77. PubMed ID: 16055718
[TBL] [Abstract][Full Text] [Related]
22. Identification of DNA-dependent protein kinase as a cofactor for the forkhead transcription factor FoxA2.
Nock A; Ascano JM; Jones T; Barrero MJ; Sugiyama N; Tomita M; Ishihama Y; Malik S
J Biol Chem; 2009 Jul; 284(30):19915-26. PubMed ID: 19478084
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of transcriptional activation of the mouse claudin-5 promoter by estrogen receptor alpha and beta.
Burek M; Steinberg K; Förster CY
Mol Cell Endocrinol; 2014 Jul; 392(1-2):144-51. PubMed ID: 24846172
[TBL] [Abstract][Full Text] [Related]
24. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation.
Duan R; Porter W; Safe S
Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor ligands ameliorate fatty liver through a nonclassical estrogen receptor/Liver X receptor pathway in mice.
Han SI; Komatsu Y; Murayama A; Steffensen KR; Nakagawa Y; Nakajima Y; Suzuki M; Oie S; Parini P; Vedin LL; Kishimoto H; Shimano H; Gustafsson JÅ; Yanagisawa J
Hepatology; 2014 May; 59(5):1791-802. PubMed ID: 24277692
[TBL] [Abstract][Full Text] [Related]
26. Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene.
Couse JF; Curtis SW; Washburn TF; Lindzey J; Golding TS; Lubahn DB; Smithies O; Korach KS
Mol Endocrinol; 1995 Nov; 9(11):1441-54. PubMed ID: 8584021
[TBL] [Abstract][Full Text] [Related]
27. Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.
Wolfrum C; Asilmaz E; Luca E; Friedman JM; Stoffel M
Nature; 2004 Dec; 432(7020):1027-32. PubMed ID: 15616563
[TBL] [Abstract][Full Text] [Related]
28. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
Swami S; Krishnan AV; Feldman D
Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
[TBL] [Abstract][Full Text] [Related]
29. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
30. Pre-marked chromatin and transcription factor co-binding shape the pioneering activity of Foxa2.
Cernilogar FM; Hasenöder S; Wang Z; Scheibner K; Burtscher I; Sterr M; Smialowski P; Groh S; Evenroed IM; Gilfillan GD; Lickert H; Schotta G
Nucleic Acids Res; 2019 Sep; 47(17):9069-9086. PubMed ID: 31350899
[TBL] [Abstract][Full Text] [Related]
31. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
32. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.
Xu H; He JH; Xiao ZD; Zhang QQ; Chen YQ; Zhou H; Qu LH
Hepatology; 2010 Oct; 52(4):1431-42. PubMed ID: 20842632
[TBL] [Abstract][Full Text] [Related]
33. Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein.
Weis KE; Ekena K; Thomas JA; Lazennec G; Katzenellenbogen BS
Mol Endocrinol; 1996 Nov; 10(11):1388-98. PubMed ID: 8923465
[TBL] [Abstract][Full Text] [Related]
34. Up-regulation of the uterine estrogen receptor and its messenger ribonucleic acid during the mouse estrous cycle: the role of estradiol.
Bergman MD; Schachter BS; Karelus K; Combatsiaris EP; Garcia T; Nelson JF
Endocrinology; 1992 Apr; 130(4):1923-30. PubMed ID: 1547720
[TBL] [Abstract][Full Text] [Related]
35. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
36. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
Rai D; Frolova A; Frasor J; Carpenter AE; Katzenellenbogen BS
Mol Endocrinol; 2005 Jun; 19(6):1606-17. PubMed ID: 15831524
[TBL] [Abstract][Full Text] [Related]
37. Methoxychlor stimulates estrogen-responsive messenger ribonucleic acids in mouse uterus through a non-estrogen receptor (non-ER) alpha and non-ER beta mechanism.
Ghosh D; Taylor JA; Green JA; Lubahn DB
Endocrinology; 1999 Aug; 140(8):3526-33. PubMed ID: 10433208
[TBL] [Abstract][Full Text] [Related]
38. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
[TBL] [Abstract][Full Text] [Related]
39. Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion.
Wolfrum C; Stoffel M
Cell Metab; 2006 Feb; 3(2):99-110. PubMed ID: 16459311
[TBL] [Abstract][Full Text] [Related]
40. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1.
Carroll JS; Liu XS; Brodsky AS; Li W; Meyer CA; Szary AJ; Eeckhoute J; Shao W; Hestermann EV; Geistlinger TR; Fox EA; Silver PA; Brown M
Cell; 2005 Jul; 122(1):33-43. PubMed ID: 16009131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]